Difference between revisions of "Team:UCSC/B-12"

 
(39 intermediate revisions by 3 users not shown)
Line 27: Line 27:
 
font-family: 'objektiv-mk1' !important;
 
font-family: 'objektiv-mk1' !important;
 
  font-size: 120%;
 
  font-size: 120%;
  font-weight: 200;
+
  font-weight: 400;
 
}
 
}
  
Line 34: Line 34:
 
   font-style: normal !important;
 
   font-style: normal !important;
 
   font-size: 140% !important;
 
   font-size: 140% !important;
   font-weight: 600 !important;
+
   font-weight: 400 !important;
 
   width: 100% !important;
 
   width: 100% !important;
 
}
 
}
Line 95: Line 95:
  
 
.proj-button:hover .proj-button-desc {
 
.proj-button:hover .proj-button-desc {
   opacity: 0.6;
+
   opacity: 0.8;
 
}
 
}
  
Line 105: Line 105:
 
   font-weight: 400 !important;
 
   font-weight: 400 !important;
 
   padding: 16px 32px;
 
   padding: 16px 32px;
 +
}
 +
 +
.diagram-image-right-1 {
 +
  width: 45%;
 +
  padding-left: 30px;
 +
  float: right;
 +
  text-align: center;
 +
  font-family: 'objektiv-mk1';
 +
  padding-bottom: 15px;
 +
  padding-top: 30px;
 +
}
 +
 +
.diagram-image-right-2 {
 +
  width: 45%;
 +
  padding-left: 30px;
 +
  float: right;
 +
  text-align: center;
 +
  font-family: 'objektiv-mk1';
 +
  /*padding-bottom: 5px;*/
 +
}
 +
 +
.diagram-image-right-3 {
 +
  width: 45%;
 +
  padding-left: 30px;
 +
  float: right;
 +
  text-align: center;
 +
  font-family: 'objektiv-mk1';
 +
  padding-bottom: 15px;
 +
  padding-top: 30px;
 +
}
 +
 +
.diagram-image-right-5 {
 +
  width: 50%;
 +
  padding-left: 30px;
 +
  float: right;
 +
  text-align: center;
 +
  font-family: 'objektiv-mk1';
 +
  padding-bottom: 15px;
 +
  padding-top: 30px;
 +
}
 +
 +
.diagram-image-left-1 {
 +
  width: 45%;
 +
  padding-right: 50px;
 +
  float: left;
 +
  text-align: center;
 +
  font-family: 'objektiv-mk1';
 +
  /*padding-bottom: 30px;*/
 +
  padding-top: 40px;
 +
  padding-bottom: 50px;
 +
}
 +
 +
.diagram-image-left-2 {
 +
  width: 52%;
 +
  padding-right: 30px;
 +
  float: left;
 +
  text-align: center;
 +
  font-family: 'objektiv-mk1';
 +
  /*padding-bottom: 5px;*/
 +
  padding-top: 15px;
 +
}
 +
 +
.diagram-image-left-3 {
 +
  width: 45%;
 +
  padding-right: 30px;
 +
  float: left;
 +
  text-align: center;
 +
  font-family: 'objektiv-mk1';
 +
  padding-bottom: 20px;
 +
  padding-top: 50px;
 +
}
 +
 +
.diagram-image-left-4 {
 +
  width: 45%;
 +
  padding-right: 30px;
 +
  float: left;
 +
  text-align: center;
 +
  font-family: 'objektiv-mk1';
 +
  padding-bottom: 20px;
 +
  padding-top: 15px;
 +
}
 +
 +
.diagram-image-center-large-1 {
 +
  width: 100%;
 +
  align-content: center;
 +
  text-align: center;
 +
  font-family: 'objektiv-mk1';
 +
  padding-bottom: 15px;
 +
  padding-top: 15px;
 +
  margin-left: -200px;
 +
    margin-right: -200px;
 
}
 
}
  
Line 196: Line 287:
 
     font-size: 16px;
 
     font-size: 16px;
 
   }
 
   }
 +
}
 +
 +
@media (min-width: 1400px) {
 +
.diagram-image-left-1 {
 +
  width: 45%;
 +
  padding-right: 50px;
 +
  float: left;
 +
  text-align: center;
 +
  font-family: 'objektiv-mk1';
 +
  /*padding-bottom: 30px;*/
 +
  padding-top: 40px;
 +
  padding-bottom: 170px;
 +
  }
 
}
 
}
  
Line 352: Line 456:
 
margin-right: -70px;
 
margin-right: -70px;
 
margin-left: -70px;
 
margin-left: -70px;
 +
}
 +
 +
.diagram-image-right-1 {
 +
    padding-left: 10px;
 +
    padding-right: 10px;
 +
    font-size: 65%;
 +
    line-height: 1.5;
 +
}
 +
 +
  .diagram-image-left-1 {
 +
    padding-right: 10px;
 +
    padding-left: 10px;
 +
    font-size: 65%;
 +
    line-height: 1.5;
 +
    width: 60%;
 +
}
 +
 +
  .diagram-image-right-2 {
 +
    padding-left: 10px;
 +
    padding-right: 10px;
 +
    font-size: 65%;
 +
    line-height: 1.5;
 +
}
 +
 +
.diagram-image-right-3 {
 +
    padding-left: 10px;
 +
    padding-right: 10px;
 +
    font-size: 65%;
 +
    line-height: 1.5;
 +
}
 +
 +
.diagram-image-right-5 {
 +
    padding-left: 10px;
 +
    padding-right: 10px;
 +
    font-size: 65%;
 +
    line-height: 1.5;
 +
}
 +
 +
  .diagram-image-left-2 {
 +
    padding-right: 10px;
 +
    padding-left: 10px;
 +
    font-size: 65%;
 +
    line-height: 1.5;
 +
}
 +
 +
.diagram-image-left-3 {
 +
    padding-right: 10px;
 +
    padding-left: 10px;
 +
    font-size: 65%;
 +
    line-height: 1.5;
 +
}
 +
 +
.diagram-image-left-4 {
 +
    padding-right: 10px;
 +
    padding-left: 10px;
 +
    font-size: 65%;
 +
    line-height: 1.5;
 +
}
 +
 +
.diagram-image-center-large-1 {
 +
width: 100%;
 +
align-content: center;
 +
text-align: center;
 +
font-family: 'objektiv-mk1';
 +
padding-bottom: 15px;
 +
padding-top: 15px;
 +
font-size: 65%;
 +
line-height: 1.5;
 
}
 
}
 
}
 
}
Line 364: Line 536:
 
       opacity: 1;
 
       opacity: 1;
 
       display: inline-block;
 
       display: inline-block;
       width: 49%;
+
       width: 50%;
 
       height: auto;
 
       height: auto;
 
       transition: .5s ease;
 
       transition: .5s ease;
Line 393: Line 565:
 
border-radius: 60px;
 
border-radius: 60px;
 
color: white;
 
color: white;
font-size: 16px;
+
font-size: 12px;
 
}
 
}
  
 
.firstword {
 
.firstword {
 
font-family: 'objektiv-mk1' !important;
 
font-family: 'objektiv-mk1' !important;
font-size: 70px;
+
font-size: 40px;
 
}
 
}
  
Line 448: Line 620:
 
padding-left: 0px;
 
padding-left: 0px;
 
padding-right: 0px;
 
padding-right: 0px;
 +
}
 +
 +
.metabolic-pathway {
 +
  margin: auto;
 +
  background: honeydew;
 +
  width: 110%;
 +
  margin-left: -20px;
 +
  margin-right: -20px;
 +
}
 +
 +
.diagram-image-left-1 {
 +
    padding-right: 40px;
 +
    padding-left: 10px;
 +
    font-size: 65%;
 +
    line-height: 1.5;
 +
    width: 65%;
 +
    padding-bottom: 15px;
 +
    }
 +
 +
    .diagram-image-center-large-1 {
 +
width: 118%;
 +
align-content: center;
 +
text-align: center;
 +
font-family: 'objektiv-mk1';
 +
padding-bottom: 15px;
 +
padding-top: 15px;
 +
font-size: 65%;
 +
line-height: 1.5;
 
}
 
}
  
Line 456: Line 656:
  
 
ol {
 
ol {
margin-left: -10px !important;
+
margin-left: 15px !important;
 
margin-right: -10px !important;
 
margin-right: -10px !important;
 
}
 
}
Line 487: Line 687:
 
<br>
 
<br>
  
<img class="titleimg" src="https://static.igem.org/mediawiki/2017/0/0d/Flask.png">
+
<img class="titleimg" src="https://static.igem.org/mediawiki/2017/0/0d/Flask.png" alt="http://www.clker.com/clipart-black-flask-1.html">
  
 
<h1>VITAMIN B<sub>12</sub> METABOLICS</h1>
 
<h1>VITAMIN B<sub>12</sub> METABOLICS</h1>
Line 505: Line 705:
 
<br>
 
<br>
  
 +
<div class="diagram-image-right-1">
 +
<img src="https://static.igem.org/mediawiki/2017/b/bf/B12_clinical_consequences.png" style="width: 100%;">
 +
<i>Clinical and health consequences of vitamin B<sub>12</sub> deficiency, adapted from Hunt Alesia et al. BMJ 2014.</i>
 +
</div>
  
<p>Most cyanobacteria, including PCC 7942 and <i>A. platensis</i>, produce pseudo vitamin B<sub>12</sub>, which is a form of vitamin B<sub>12</sub> that is inactive in mammals<sup>[10, 11]</sup>. Active B<sub>12</sub> is important for nucleotide synthesis and the human metabolism of branched amino acids and odd-chain fatty acids. It acts as a cofactor in synthesis of methionine and succinyl-CoA<sup>[12]</sup>. Methionine is an essential amino acid; its upregulation increases biological value by cellular protein composition<sup>[13]</sup>. Increased vitamin B<sub>12</sub> levels upregulates methionine synthesis, causing an increase in biological value. An increase in methionine levels additionally boosts vitamin B<sub>9</sub> (folate) availability<sup>[14]</sup>.</p>
+
<h2 style="text-align: left; font-weight: 400;">The Vitamin B<sub>12</sub> Dilemma</h2>
 
<br>
 
<br>
  
<p>Active vitamin B<sub>12</sub> proves to be a leading global vitamin deficiency and one of the most difficult vitamins to naturally consume, especially for vegetarians<sup>[15]</sup>. Vitamin B<sub>12</sub> deficiency can lead to megaloblastic anemia and demyelinating nervous system disease<sup>[16]</sup>. Additionally, both vitamins B<sub>12</sub> and B<sub>9</sub> are considered important prenatal vitamins for nervous system development<sup>[17]</sup>.</p>
+
<ol style="text-align: left; font-family: 'objektiv-mk1'; font-size: inherit;">
 +
<li>Most cyanobacteria, including <i>S. elongatus</i> PCC 7942 and <i>A. platensis</i>, produce vitamin B<sub>12</sub> analogs, which are forms of vitamin B<sub>12</sub> that mammals cannot absorb<sup>[10,11]</sup>.</li>
 +
<br>
 +
<li>Vitamin DMB B<sub>12</sub>, which is the only form of vitamin B<sub>12</sub> that mammals can absorb, is crucial for nucleotide synthesis, methionine synthesis, nervous system function, neurodevelopment, and metabolism of folate, branched amino acids, and odd-chain fatty acids in humans<sup>[12,16,19]</sup>.</li>
 +
<br>
 +
<li>Vitamin DMB B<sub>12</sub> proves to be a leading global vitamin deficiency and one of the most difficult vitamins to naturally consume <sup>[15]</sup>.</li>
 +
<br>
 +
<li>Vitamin B<sub>12</sub> deficiency can lead to a wide array of symptoms and diseases.</li>
 +
<br>
 +
</ol>
  
<div class="container">
+
<br>
<div class="row">
+
<br>
<div class="col-md-7">
+
 
<div class="mainp">What makes Vitamin B<sub>12</sub> active?</div>
+
 
 +
<!-- <p>Most cyanobacteria, including PCC 7942 and <i>A. platensis</i>, produce pseudo vitamin B<sub>12</sub>, which is a form of vitamin B<sub>12</sub> that is inactive in mammals<sup>[10, 11]</sup>. Active B<sub>12</sub> is important for nucleotide synthesis and the human metabolism of branched amino acids and odd-chain fatty acids. It acts as a cofactor in synthesis of methionine and succinyl-CoA<sup>[12]</sup>. Methionine is an essential amino acid; its upregulation increases biological value by cellular protein composition<sup>[13]</sup>. Increased vitamin B<sub>12</sub> levels upregulates methionine synthesis, causing an increase in biological value. An increase in methionine levels additionally boosts vitamin B<sub>9</sub> (folate) availability<sup>[14]</sup>.</p>
 +
<br>
 +
 
 +
<p>Active vitamin B<sub>12</sub> proves to be a leading global vitamin deficiency and one of the most difficult vitamins to naturally consume, especially for vegetarians<sup>[15]</sup>. Vitamin B<sub>12</sub> deficiency can lead to megaloblastic anemia and demyelinating nervous system disease<sup>[16]</sup>. Additionally, both vitamins B<sub>12</sub> and B<sub>9</sub> are considered important prenatal vitamins for nervous system development<sup>[17]</sup>.</p> -->
 +
 
 +
 
 +
<div class="diagram-image-left-1">
 +
<img src="https://static.igem.org/mediawiki/2017/d/db/B12_%281%29.png" style="width: 100%;">
 +
<i>Vitamin B<sub>12</sub> (a) structure composed of Cobalmin with a corrin ring and centralized cobalt (1) and a lower ligand, which can be constructed from DMB (2) or adenine (3) <sup>[12]</sup>.</i>
 +
</div>
 +
 
 +
<h2 style="text-align: left; font-weight: 400;">What makes Vitamin B<sub>12</sub> active?</h2>
 +
<br>
 +
 
 +
<ol style="text-align: left; font-family: 'objektiv-mk1'; font-size: inherit;">
 +
<li>Vitamin B<sub>12</sub> is composed of a corrin ring, centralized cobalt, and covalently bound upper and lower axial ligands<sup>[12,18]</sup>.</li>
 +
<br>
 +
<li>For vitamin B<sub>12</sub> to be active in mammals, the lower ligand must be constructed with 5,6-dimethylbenzimidazole and α-ribosole-5-phosphate<sup>[12]</sup> effectively creating vitamin DMB B<sub>12</sub>.</li>
 +
<br>
 +
<li>Without these two compounds, the cell cannot synthesize the 5,6-dimethylbenzimidazolyl nucleotide moiety (5,6-DMB) de novo and instead uses cellular adenine as the lower ligand, creating B<sub>12</sub> analogs<sup>[11,12]</sup>.</li>
 +
<br>
 +
<li>5,6-DMB, as a lower ligand, binds the glycoprotein intrinsic factor to cobalamin, which aids in transport of the B<sub>12</sub> molecule within the mammalian gastrointestinal tract<sup>[12]</sup>.</li>
 +
<br>
 +
<li>Without the glycoprotein intrinsic factor, vitamin B<sub>12</sub> cannot be absorbed<sup>[16]</sup>.</li>
 +
</ol>
 +
 
 +
<!-- <div class="mainp">What makes Vitamin B<sub>12</sub> active?</div>
 
<br>
 
<br>
 
<ol style="text-align: left; font-family: 'objektiv-mk1'; font-size: inherit;">
 
<ol style="text-align: left; font-family: 'objektiv-mk1'; font-size: inherit;">
Line 530: Line 770:
 
<div class="col-md-5">
 
<div class="col-md-5">
 
<img src="https://static.igem.org/mediawiki/2017/d/db/B12_%281%29.png" style="width: 95%; padding-top: 20px;">
 
<img src="https://static.igem.org/mediawiki/2017/d/db/B12_%281%29.png" style="width: 95%; padding-top: 20px;">
<figcaption>Vitamin B<sub>12</sub> (a) structure composed of Cobalmin with a corrin ring and centralized cobalt (1) and a lower ligand, which can be constructed from DMB (2) or adenine (3). (b) The reaction from FMNH<sub>2</sub> (4) to DMB catalyzed by the bluB gene. (c) The reaction from DMB to α-ribazole (5) catalyzed by cobT<sup>[12]</sup>.</figcaption>
+
<figcaption>Vitamin B<sub>12</sub> (a) structure composed of Cobalmin with a corrin ring and centralized cobalt (1) and a lower ligand, which can be constructed from DMB (2) or adenine (3) <sup>[12]</sup>.</figcaption>
 
</div>
 
</div>
 
</div>
 
</div>
 +
</div> -->
 +
 +
<br>
 +
<br>
 +
<br>
 +
 +
<h2 style="text-align: center; font-weight: 400;">How Vitamin DMB B<sub>12</sub> Is Synthesized</h2><br>
 +
 +
<div class="diagram-image-center-large-1">
 +
<img src="https://static.igem.org/mediawiki/2017/2/21/B12_pathway.png" style="width: 100%;">
 +
<i>Vitamin DMB B<sub>12</sub> synthesis follows the pathway map above, adapted from Metacyc; the pink genes are absent in S. elongatus PCC 7942</i>
 
</div>
 
</div>
  
 +
<!-- <div class="metabolic-pathway">
 +
<img src="https://static.igem.org/mediawiki/2017/c/c5/B12-syn.png" style="width: 100%;">
 +
</div> -->
 +
<br>
 +
<br>
 +
 +
<h2 style="text-align: center; font-weight: 400;">Our Mechanism of Action</h2><br>
 +
 +
<ol style="text-align: left; font-family: 'objektiv-mk1'; font-size: inherit;">
 +
<li>The genes <i>ssuE</i> and <i>bluB</i> are absent in <i>S. elongatus</i> PCC 7942.</li>
 +
<br>
 +
<li>In order to induce the synthesis of DMB B<sub>12</sub> in <i>S. elongatus</i> PCC 7942, these previously absent genes must be artificially integrated into the organism’s genome.</li>
 +
<br>
 +
<li>The insertion of these genes will allow 5,6-DMB to be synthesized within the host.</li>
 +
<br>
 +
<li><i>S. elongatus</i> PCC 7942 has the necessary genes (<i>cobU</i>, <i>pgam3</i>, <i>IdiB</i>, <i>cobS</i>) to complete the synthesis of vitamin B<sub>12</sub> using 5,6-DMB as the lower ligand.</li>
 +
<br>
 +
<li>The result: intracellular production of vitamin DMB B<sub>12</sub> within <i>S. elongatus</i> PCC 7942.</li>
 +
</ol>
 +
 +
<br>
 
<br>
 
<br>
  
<div class="metabolic-pathway">
+
<div class="diagram-image-center-large-1">
<img src="" style="width: 100%;">
+
<img src="https://static.igem.org/mediawiki/2017/c/c5/B12-syn.png" style="width: 100%;">
 
</div>
 
</div>
  
<div class="container">
+
 
 +
<!-- <div class="container">
 
<div class="mainp">Our mechanism of action</div>
 
<div class="mainp">Our mechanism of action</div>
 
<br>
 
<br>
Line 555: Line 828:
 
<li>The result is synthesis of active vitamin B<sub>12</sub> within PCC 7942.</li>
 
<li>The result is synthesis of active vitamin B<sub>12</sub> within PCC 7942.</li>
 
</ol>
 
</ol>
</div>
+
</div> -->
  
  
Line 565: Line 838:
 
<div class="row">
 
<div class="row">
 
<div class="col-md-4">
 
<div class="col-md-4">
<h3><b>Project Homepage</b></h3>
+
<h3>P R O J E C T</h3>
 
<hr>
 
<hr>
 
<a href="https://2017.igem.org/Team:UCSC/Project" class="proj-button">
 
<a href="https://2017.igem.org/Team:UCSC/Project" class="proj-button">
<img src="https://static.igem.org/mediawiki/2017/0/0b/Cyano_button_icon.png" class="proj-button-image-solo">
+
<img src="https://static.igem.org/mediawiki/2017/6/64/UCSCproject.png" class="proj-button-image-solo">
 
<div class="proj-button-desc">
 
<div class="proj-button-desc">
<div class="overlap-button-text">PROJECT</div>
+
<div class="overlap-button-text">HOMEPAGE</div>
 
</div>
 
</div>
 
</a>
 
</a>
Line 576: Line 849:
  
 
<div class="col-md-8">
 
<div class="col-md-8">
<h3><b>Click here to learn more!</b></h3>
+
<h3>Click here to learn more!</h3>
 
<hr>
 
<hr>
 
<div class="row">
 
<div class="row">
Line 603: Line 876:
  
 
<a href="https://2017.igem.org/Team:UCSC/Target-Organism" class="proj-button">
 
<a href="https://2017.igem.org/Team:UCSC/Target-Organism" class="proj-button">
    <img src="https://static.igem.org/mediawiki/2017/0/0b/Cyano_button_icon.png" class="proj-button-image">
+
    <img src="https://static.igem.org/mediawiki/2017/8/84/Spirulinaicon.png" class="proj-button-image">
 
    <div class="proj-button-desc">
 
    <div class="proj-button-desc">
    <div class="overlap-button-text">SPIRULINA</div>
+
    <div class="overlap-button-text">TARGET ORGANISM</div>
 
    </div>
 
    </div>
 
</a>
 
</a>
  
<a href="https://2017.igem.org/Team:UCSC/Parts" class="proj-button">
+
<a href="https://2017.igem.org/Team:UCSC/Part_Collection" class="proj-button">
 
    <img src="https://static.igem.org/mediawiki/2017/9/9c/Parts_icon.png" class="proj-button-image">
 
    <img src="https://static.igem.org/mediawiki/2017/9/9c/Parts_icon.png" class="proj-button-image">
 
    <div class="proj-button-desc">
 
    <div class="proj-button-desc">
Line 631: Line 904:
 
<li>[16] S. P. Stabler, “Vitamin B12 Deficiency,” <i>New England Journal of Medicine</i>, vol. 368, pp. 149-160, Jan. 2013.</li>
 
<li>[16] S. P. Stabler, “Vitamin B12 Deficiency,” <i>New England Journal of Medicine</i>, vol. 368, pp. 149-160, Jan. 2013.</li>
 
<li>[17] M. T. Steen, A. M. Boddie, A. J. Fisher, W. Macmahon, D. Saxe, K. M. Sullivan, P. P. Dembure, and L. J. Elsas, “Neural-tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid,” <i>Prenatal Diagnosis</i>, vol. 18, pp. 545-555, June 1998.</li>
 
<li>[17] M. T. Steen, A. M. Boddie, A. J. Fisher, W. Macmahon, D. Saxe, K. M. Sullivan, P. P. Dembure, and L. J. Elsas, “Neural-tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid,” <i>Prenatal Diagnosis</i>, vol. 18, pp. 545-555, June 1998.</li>
 +
<li>[18] S. A. Newmister, C. H. Chan, J. C. Escalante-Semerena, and I. Rayment, “Structural Insights into the Function of the Nicotinate Mononucleotide:phenol/p-cresol Phosphoribosyltransferase (ArsAB) Enzyme from Sporomusa ovata,” Biochemistry, vol. 51, pp. 8571–8582, Oct. 2012.</li>
 +
<li>[19] Hunt Alesia, Harrington Dominic, Robinson Susan. Vitamin B12 deficiency BMJ 2014; 349 :g5226.</il>
 
</div>
 
</div>
 
</div>
 
</div>

Latest revision as of 00:06, 2 November 2017



http://www.clker.com/clipart-black-flask-1.html

VITAMIN B12 METABOLICS


“Vitamin B12 deficiency is a common but serious condition...a deficiency may lead to disruption of DNA and cell metabolism and thus have serious clinical consequences.”

~Hunt Alesia et al. BMJ 2014





Clinical and health consequences of vitamin B12 deficiency, adapted from Hunt Alesia et al. BMJ 2014.

The Vitamin B12 Dilemma


  1. Most cyanobacteria, including S. elongatus PCC 7942 and A. platensis, produce vitamin B12 analogs, which are forms of vitamin B12 that mammals cannot absorb[10,11].

  2. Vitamin DMB B12, which is the only form of vitamin B12 that mammals can absorb, is crucial for nucleotide synthesis, methionine synthesis, nervous system function, neurodevelopment, and metabolism of folate, branched amino acids, and odd-chain fatty acids in humans[12,16,19].

  3. Vitamin DMB B12 proves to be a leading global vitamin deficiency and one of the most difficult vitamins to naturally consume [15].

  4. Vitamin B12 deficiency can lead to a wide array of symptoms and diseases.



Vitamin B12 (a) structure composed of Cobalmin with a corrin ring and centralized cobalt (1) and a lower ligand, which can be constructed from DMB (2) or adenine (3) [12].

What makes Vitamin B12 active?


  1. Vitamin B12 is composed of a corrin ring, centralized cobalt, and covalently bound upper and lower axial ligands[12,18].

  2. For vitamin B12 to be active in mammals, the lower ligand must be constructed with 5,6-dimethylbenzimidazole and α-ribosole-5-phosphate[12] effectively creating vitamin DMB B12.

  3. Without these two compounds, the cell cannot synthesize the 5,6-dimethylbenzimidazolyl nucleotide moiety (5,6-DMB) de novo and instead uses cellular adenine as the lower ligand, creating B12 analogs[11,12].

  4. 5,6-DMB, as a lower ligand, binds the glycoprotein intrinsic factor to cobalamin, which aids in transport of the B12 molecule within the mammalian gastrointestinal tract[12].

  5. Without the glycoprotein intrinsic factor, vitamin B12 cannot be absorbed[16].



How Vitamin DMB B12 Is Synthesized


Vitamin DMB B12 synthesis follows the pathway map above, adapted from Metacyc; the pink genes are absent in S. elongatus PCC 7942


Our Mechanism of Action


  1. The genes ssuE and bluB are absent in S. elongatus PCC 7942.

  2. In order to induce the synthesis of DMB B12 in S. elongatus PCC 7942, these previously absent genes must be artificially integrated into the organism’s genome.

  3. The insertion of these genes will allow 5,6-DMB to be synthesized within the host.

  4. S. elongatus PCC 7942 has the necessary genes (cobU, pgam3, IdiB, cobS) to complete the synthesis of vitamin B12 using 5,6-DMB as the lower ligand.

  5. The result: intracellular production of vitamin DMB B12 within S. elongatus PCC 7942.







  • [10] K. E. Helliwell, A. D. Lawrence, A. Holzer, U. J. Kudahl, S. Sasso, B. Kr ̈autler, D. J. Scanlan, M. J. Warren, and A. G. Smith, “Cyanobacteria and Eukaryotic Algae Use Different Chemical Variants of Vitamin B12,” Current biology: CB, vol. 26, pp. 999–1008, Apr. 2016.
  • [11] V. Karuppiah, W. Sun, and Z. Li, “Natural Products of Actinobacteria Derived from Marine Organisms,” in Studies in Natural Products Chemistry, vol. 48, pp. 417-446, Elsevier, 2016. DOI: 10.1016/B978-0-444-63602-7.00013-8.
  • [12] P. Deptula, P. Kylli, B. Chamlagain, L. Holm, R. Kostiainen, V. Piironen, K. Savijoki, and P. Varmanen, “BluB/CobT2 fusion enzyme activity reveals mechanisms responsible for production of active form of vitamin B12 by Propionibacterium freudenreichii,” Microbial Cell Factories, vol. 14, p. 186, Nov. 2015.
  • [13] D. L. R. Narasimha, G. S. Venkataraman, S. K. Duggal, and B. O. Eggum, “Nutritional quality of the blue-green alga Spirulina platensis geitler,” Journal of the Science of Food and Agriculture, vol. 33, pp. 456{460, May 1982.
  • [14] M. Fenech, “Folate (vitamin B9) and vitamin B12 and their function in the maintenance of nuclear and mitochondrial genome integrity,” Mutation Research, vol. 733, pp. 21-33, May 2012.
  • [15] B. Hemmer, F. X. Glocker, M. Schumacher, G. Deuschl, and C. H. Lucking, “Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 65, pp. 822-827, Dec. 1998.
  • [16] S. P. Stabler, “Vitamin B12 Deficiency,” New England Journal of Medicine, vol. 368, pp. 149-160, Jan. 2013.
  • [17] M. T. Steen, A. M. Boddie, A. J. Fisher, W. Macmahon, D. Saxe, K. M. Sullivan, P. P. Dembure, and L. J. Elsas, “Neural-tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid,” Prenatal Diagnosis, vol. 18, pp. 545-555, June 1998.
  • [18] S. A. Newmister, C. H. Chan, J. C. Escalante-Semerena, and I. Rayment, “Structural Insights into the Function of the Nicotinate Mononucleotide:phenol/p-cresol Phosphoribosyltransferase (ArsAB) Enzyme from Sporomusa ovata,” Biochemistry, vol. 51, pp. 8571–8582, Oct. 2012.
  • [19] Hunt Alesia, Harrington Dominic, Robinson Susan. Vitamin B12 deficiency BMJ 2014; 349 :g5226.